Heterologous prime-boost immunotherapy of melanoma patients with Influenza virosomes, and recombinant Vaccinia virus encoding 5 melanoma epitopes and 3 co-stimulatory molecules. A multi-centre phase I/II open labeled clinical trial
Michel Adamina, Walter P. Weber, Rachel Rosenthal, Reto Schumacher, Paul Zajac, Ulrich Guller, Daniel M. Frey, Daniel Oertli, Markus Zuber, Michael Heberer, Giulio C. SpagnoliVolume:
29
Year:
2008
Language:
english
Pages:
182
DOI:
10.1016/j.cct.2007.07.002
File:
PDF, 433 KB
english, 2008